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INSIGHTS INTO THE CATALYTIC MECHANISM OF RETRO-ALDOL 
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Master of Science at Virginia Commonwealth University. 
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Major Director: Martin K. Safo. PhD                                                                                 
Associate Professor, Department of Medicinal Chemistry 
 
With over 140 vitamin B6 (Pyridoxal 5’-phosphate, PLP) dependent enzymes, 
serving vital roles in various transamination, decarboxylation, retro-aldol cleavage and 
synthesis pathways these enzymes constitute the most versatile catalytic systems in 
nature. Enzymes of this group have an inherent reaction as well as substrate specificity. A 
single co-factor namely, PLP is used by specific enzymes of this group to serve distinct 
roles during the catalytic reaction. An ordered evolutionary adaptation in these enzymes 
has led to specialization achieved by each enzyme for catalyzing specific reactions. 
 L-Threonine aldolase (L-TA) is one such PLP- dependent enzyme that catalyzes 
the retro-aldol cleavage of several β-hydroxy amino acids, although its natural substrates 
are L-threonine and L-allo-threonine with the enzyme having significant preference for 
L-allo-threonine. It also catalyzes racemization and transamination of D-alanine but not 
of the β-hydroxy amino acids. Thus, the enzyme exhibits both substrate and reaction 
xi 
 
specificity. Although, L-TA is frequently employed for stereoselective synthesis of 
pharmaceutically useful compounds, its reaction mechanism and associated specificity is 
still not clearly understood. 
L-TA from Escherichia coli (eTA) is being studied in our laboratory.  Our 
objective is to elucidate the catalytic mechanism of eTA and its mode of substrate and 
reaction specificity using X-ray crystallography. Another objective is to establish 
evolutionary relationship of L-TA with other B6-dependent enzymes, such as serine 
hydroxymethyltransferase (SHMT) and Thermatoga maritima L-TA (TTA) that have the 
same fold and catalyze similar reactions.  
Our structural studies show that while the crystal structures of the two L-TAs are 
similar, they are significantly different from that of SHMT, especially at the active site. 
In the L-TA structures, a loop with proposed important active site residue, His126 is 
replaced by tetrahydrofolate (THF) in SHMT. 
The crystal structures of eTA in its native form and in complex with substrate or 
product have highlighted the importance of His126 in ensuring substrate specificity 
during retro-aldol cleavage of various β-hydroxy amino acids and His83 or a conserved 
water molecule to be active site base. Our study emphasizes the molecular level 
implications of the catalytic mechanism of eTA.  
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CHAPTER 1 General Introduction 
 
1.1 L-Threonine and L-Threonine aldolase:  
L-Threonine is one of the amino acids required for protein synthesis. Since there 
is no de novo pathway for the synthesis of L-threonine in human beings, the amino acid 
needs to be supplemented for in a protein rich diet.  Also, its catabolism (in general, 
amino acid catabolism) supports gluconeogenesis during starvation. Besides the amino 
acid is ketorgenic entering important metabolic cycles at various locations. 
L-threonine degradation pathway (Figure 1) includes the enzymes L-threonine 
dehydratase (L-TD) as well as L-threonine 3-dehydrogenase (TDH) and L-threonine 
aldolase (L-TA). The dehydratase pathway generates α-ketobutyrate from L-threonine 
which enters the tri-carboxylic acid cycle (TCA) as succinyl-CoA. TDH metabolizes L-
threonine to 2-keto 3-ketobutyrate and subsequently yields acetyl-CoA which is also an 
intermediate in TCA. The two enzymes collectively account for more than 80% of L-
threonine metabolism.
1
  
2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: L-Threonine degradation pathway. The major enzymes that are 
involved in the pathway are shown here.  
 
 
 
The third enzyme in threonine degradation, L-TA, has minimal role in threonine 
metabolism.
1 
L-TA belongs to the large group of enzymes that require the cofactor, 
pyridoxal 5’-phophate (PLP), to function. It catalyzes the retro-aldol cleavage of β-
 
L-threonine 
 
L-threonine dehydratase  L-threonine 3-dehydrogenase  
α-ketobutyrate 
2-keto 3-ketobutyrate 
Succinyl Co-A Acetyl Co-A 
Tricarboxylic     
Acid Cycle 
  
3 
 
hydroxy amino acids which may be L-threonine, L-allo-threonine or L-serine, although 
the natural substrates of the enzyme are L-threonine and L-allo- threonine. Our interest in 
the enzyme arises from the fact that, L-TA catalyzes reactions which are considered as 
‘forced errors’ for other enzymes that use PLP as a co-factor.2  
Orthologous genes encoding L-threonine aldolase from varied microorganisms 
such as Escherichia coli, yeast and Candida albicans, have been cloned and expressed.
3
 
Enzyme activity was detected in tissue preparations and in liver cells in vertebrates. In 
humans the enzyme is a non-transcribed pseudogene.
4
  
The general reaction catalyzed by the enzyme may be represented as; 
 
 
      β-hydroxy amino acid             aldehyde               glycine 
 
Depending on the source of the enzyme, L-TAs show significantly different 
substrate specificities. The enzyme isolated from Lactobacillus bulgaricus is highly 
specific for L-threonine while the enzyme isolated from Aeromonas jandaei is very 
selective towards L-allo-threonine.
3
 Escherichia coli L-TA (eTA) being studied in our 
laboratory, is a low specificity L-TA capable of cleaving both L-threonine and L-allo-
threonine. Nonetheless, kinetic studies (Table 1) have revealed that L-allo-threonine is 
the preferred substrate.
2
    
            
 
L-TA 
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Table 1: Kinetic data depicting substrate specificity for L-TAs from different sources.
2, 5
 
Aeromonas jandaei selectively catalyzes the retro-aldol cleavage of only L-allo-Thr as 
indicated by the absence of Km value for L-Thr cleavage by A. jandaei L-TA 
Source  
 
Reaction catalyzed 
      Escherichia coli 
Km (mM) 
     Aeromonas jandaei 
 Km (mM) 
L-threonine cleavage     10                     
L-allo-threonine 
cleavage 
    0.19   0.37   
      
In addition to the retro-aldol cleavage reaction, eTA also catalyzes transamination 
and racemization of D-alanine.
2
  Representative reactions are shown below; 
1.Transamination: 
 
 
 
2. Racemization: 
 
 
 
 
 
 
Kinetic studies (Table 2) of the transamination and racemization have revealed 
that these reactions proceed at much lower rates as compared to the retro-aldol cleavage 
reaction. 
or Pyruvate + PMP                    
L-TA / PLP 
L-TA   
D- or L- alanine            
              L- alanine                                                        D-alanine        
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Table 2. Kinetic data depicting rate of transamination and racemization reaction.
2
 
Reaction  
 
     kcat(min
-1
)      Km (mM) kcat/ Km (mM
-1  
min
-1
) 
L-alanine 
transamination  
       0.114 225 0.0005 
 
D-alanine 
transamination 
0.109 77 0.0014 
 
Alanine racemization  0.27 77 0.0035 
  
In summary, eTA preferentially catalyzes the retro-aldol cleavage of L-allo-
threonine over other β-hydroxy amino acids. It also selectively catalyzes the retro-aldol 
cleavage of   β-hydroxy amino acids over transamination or racemization of D-alanine. It 
is quite intriguing how the enzyme achieves both reaction and substrate specificity.  
  1.2 L-Threonine aldolase as a biocatalyst:  
Biocatalysis or controlled enzymatic catalysis provides a unique avenue for the 
stereo- and regio-selective synthesis of chemical moieties. With the advancements in 
protein and enzyme engineering, biocatalysis has developed into a very promising tool 
for synthetic chemists. Enzymes purified to homogeneity as well as whole host cells have 
been employed in synthesis of chemical and pharmaceutical intermediates.
6
  
L-Threonine aldolase (L-TA) is widely used as a biocatalyst. L-TA has been 
employed in the resolution of stereo-isomers as well as in the single step catalytic 
synthesis of specific stereo-isomers in excess of the other. The latter method generally is 
more productive in terms of yield and the enantiomeric excess of the required product.
3
 
The enzyme finds use in the synthesis of polyoxins
7
 and of chiral building blocks 
for drugs like L-threo-β-(3, 4-dihydroxy) serine for treatment of Parkinson’s disease.8 
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The enzyme has found use in the synthesis of ω-carboxy- β-hydroxy-(L)-α-amino acids.9 
L-threonine aldolase has also been utilized in the synthesis of glycoconjugate 
precursors.
10
 
L-TA has been reported as a biocatalyst for the stereoselective synthesis of β-
hydroxy amino acids from glycine and aliphatic or aromatic aldehydes. If glycine and 
aliphatic aldehydes are used as substrates, the erythro-β-hydroxy amino acids are the 
major products, while the use of aromatic aldehydes leads to threo-β-hydroxy amino 
acids as the major products.
11
 L-TA purified from Pseudomonas putida has provided new 
routes for the synthesis of industrially important amino acids like L-β-(3, 4-
dihydroxyphenyl) serine and L- β-phenylserine.12 L-TA purified from Pseudomonas 
putida has also been applied to achieve diastreoselectivity and better yields of the 
versatile γ –halogenated- β-hydroxy-α- amino acids. These compounds have found use as 
enzyme inhibitors, for control of allergies and for tumor suppression. With glycine, the 
fluoro-aldehydes gave better diastereoselectivity (in favor of syn conformation) and yield 
compared to other halogenated aldehydes. Use of higher carbon analogues (C9 and 
above) of the aldehyde resulted in reversal of diastereoselectivity with the anti 
conformation being favored. The reversal in diastereoselectivity is attributed to the size 
of the hydrophobic pocket of the enzyme that lacks favorable interactions with long chain 
aldehydes.
13
 
L-TA catalyzed retro-aldol cleavage reaction is an equilibrium reaction and 
controlling the reaction in favor of the formation of an aldol product is a challenge. Also, 
the aldehydes have reduced solubility in the reaction conditions generally employed for 
carrying out catalysis. The utility of L-TA in organic synthesis is immense at the 
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laboratory scale but to make it industrially viable further optimization of the enzyme is 
required. Future work to improve L-TA as a biocatalyst may employ protein engineering 
to improve the enzyme to achieve better diastereoselectivity and synthetic activity. Also, 
to solve the problem of solubility of aldehydes, L-TA may be immobilized or a two-
phase reaction system may be employed.
3
 
1.3 L-TA, a B6 requiring enzymes: 
There are over 140 vitamin B6 (PLP-dependent) enzymes, serving vital roles in 
various transamination, decarboxylation, retro-aldol cleavage and synthesis pathways 
involving glucose and lipid metabolism, amino acid and homocysteine metabolism, heme 
and DNA/RNA synthesis and neurotransmitter production.
14
 Understanding of the 
functioning of PLP- dependent enzymes has increased remarkably over the last twenty 
years owing to the large number of sequences and crystal structures of the enzymes 
becoming available.
15, 16
 Enzymes of this group have an inherent reaction as well as 
substrate specificity. Each enzyme possesses the necessary apparatus to modulate the use 
of a single co-factor, PLP, in the catalytic reaction. Selectivity in substrates and reactions 
for each enzyme is a consequence of an ordered evolutionary adaptation in these 
enzymes. There are extensive reviews available in the literature on PLP-dependent 
enzyme, including catalysis, reaction specificity and evolutionary relationship between 
the enzymes.
14-19
 These enzymes are described in greater details hereunder; 
1.3.1 Structural Diversity within PLP-dependent enzymes with emphasis on fold 
type I:  
PLP-dependent enzymes are categorized into five or six structurally distinct fold 
types. It has been recognized that there is no correlation between fold types and reaction 
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types, i.e., enzymes belonging to same fold may represent catalysis of versatile reactions. 
The most well understood of the six different fold types of this evolutionarily conserved 
family of enzymes is Fold Type I. Aspartate aminotransferase is the prototype for the 
enzymes in this fold type.
15, 16
 Serine hydroxymethyltransferase (SHMT) and L-TA are 
other examples of B6 enzymes belonging to Fold Type I.  
Figure 2 is a schematic representation of structure of Fold type I enzymes
18
. Fold 
Type I enzymes catalytically active as homodimers with each subunit made of two 
domains, namely the large and the small domain. The large domain features seven β-
stranded sheets with interlinking α-helices. The small domain comprises of the C-
terminus folded into three to four β-stranded sheets with α-helices on one side. The N-
terminal also usually contributes to the small domain.  The aldehyde group of PLP binds 
to a conserved lysine residue of the large domain forming an internal aldimine linkage 
with the amine group of lysine.
18
 In general, active site is located at the interface of the 
two closely associated monomeric subunits forming a tight dimer.
14, 16
 Residues from 
both the subunits contribute to the catalytic mechanism.
18
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Figure 2: Schematic representation
17
 of overall structure of Fold Type I enzymes. 
Yellow circles are the α-helices and blue triangles are the β-sheets of the large domain. 
Orange circles are the α-helices and the cyan triangles are the β-sheets of the small 
domain  
 
1.3.2 Achieving Reaction and Substrate Specificity in PLP-dependent enzymes: 
PLP is very reactive and readily forms a Schiff base (an aldimine linkage) with 
the N-terminus of amino acids through its aldehyde group. This is termed external 
aldimine. When it forms an aldimine linkage with the active site Lys in the B6 enzymes, it 
is called an internal aldimine (Figure 3). PLP is also an ‘electron sink’ which can 
withdraw electrons from a wide variety of substrates accounting for its success as a co-
enzyme for such a wide array of reactions. But the protein (enzyme) to which PLP is 
bound as a Schiff base provides the necessary apparatus to ensure reaction and substrate 
specificity.
14
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a.                                                             b.  
 
 
 
Figure 3: Schematic representation
14
 of Schiff base between a. with N-terminus of amino 
acid (forming an external aldimine) and b. with N-terminus of Lys residue of the protein 
(forming an internal aldimine) 
 
Several general hypotheses have been proposed to explain the reaction and 
substrate specificity achieved by the PLP-dependent enzymes. Two of these are briefly 
explained below.  
Dunathan hypothesis: 
Dunathan proposed that the geometry of aldimine linkage directs the bond 
cleavage in reactions catalyzed by enzymes using PLP as a co-factor. He suggested that 
the bond to be broken aligns perpendicular to the plane of the aldimine linkage and 
pyridine ring of PLP. He reasoned that this ensures maximum σ-π interaction during 
transition state.
14
 Thus, one way to distinguish between deprotonation and 
decarboxylation, for example is by orienting the substrate differently in these different 
reactions (Figure 4).  
 
 
 
 
 
Amino acid  
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a.  
 
b.  
 
 
c. 
 
 
 
Figure 4: a. Substrate orientation for deprotonation reaction; b. Substrate orientation for 
decarboxylation reaction; c. Schematic representation of σ-π orbital overlap for 
maximum interaction
17 
 
Closed conformation:  
Studies with aspartate aminotransferase
20
 and SHMT
18, 19, 21   
indicate that during 
the enzyme catalyzed reaction there is an equilibrium between an open and closed state of 
the enzymes. It is generally accepted for aspartate aminotransferase that with C4 
substrates like L-aspartate the enzyme undergoes a conformational change from open to 
closed form and the entire reaction proceeds in the closed state. In case of SHMT, 
reaction specificity is achieved when the enzyme is in the closed conformation.
18, 19, 21
 
The schematic in Figure 5 describes the open and closed structures specific for 
aspartate aminotransferase.
20 
 
 
Deprotonation  
Decarboxylation  
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Figure 5: Schematic representation of open and closed structures in aspartate 
aminotransferase.
20
  
 
 
1.3.3 Serine hydroxymethyltransferase and L-TA: 
There are excellent and extensive reviews available on the studies of SHMT.
22-24
 
Most of the SHMTs characterized to date are either homotetramers (rabbit SHMT) or 
homodimers in solution (E. coli SHMT). 
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Historically, SHMT was thought to possess residual L-TA activity
25
. Recently, L-
TA has been established as a ‘genuine’ enzyme with L-TA from several microbial 
sources being cloned and expressed.
3, 26-28
 
SHMT is a well established enzyme in serine metabolism pathway. The 
physiological reaction catalyzed by SHMT is the retro-aldol cleavage of L-Serine to form 
glycine and formaldehyde in the presence of a second co-factor, tetrahydrofolate (THF), a 
one-carbon donor that participates in nucleic acid biosynthesis. The formaldehyde then 
reacts non-enzymatically with the bound THF at the active site.
21-24, 29
 The enzyme fails 
to catalyze this reaction in the absence of THF. The retro-aldol cleavage reaction of L-
serine by SHMT is represented below. 
 
 
 
 
   L-Serine                                            Glycine                          Formaldehyde          
                                                                                                           
                          5, 10-CH-H4PteGlu                            5, 10-CH2- H4PteGlu 
 
Formaldehyde                Tetrahydrofolic acid                           Methyl-tetrahydrofolic acid 
 
In the absence of THF, SHMT can function like L-TA, catalyzing the retro-aldol 
cleavage of other amino acids like L-threonine and L-allo-threonine.
30
 Racemization and 
transamination reactions of D-alanine by SHMT are also known.
31
 The specificity of 
SHMT towards retro-aldol cleavage of L-Serine has perplexed scientists and has led to 
detailed study of SHMT to understand its mechanistic implications. 
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 Figure 6 depicts the crystal structure of eSHMT which shows external aldimine 
linkage to PLP with product glycine after a retro-aldol cleavage of the substrate L-
Serine.
28
   
 
 
 
 
 
 
 
 
 
 
 
Figure 6: THF (purple) is seen in the figure along with other active site residues (green) 
 
 
Specific residues at the active site of SHMT have been established as controllers 
of the reaction of the enzyme and research has been focused on the stereochemistry at Cβ 
carbon of β-hydroxy amino acids (Figure 6).32-41 The catalytically important unit of 
eSHMT is a tight dimer formed by two monomeric subunits. 
 
A conserved lysine residue 
(Lysine 229 of eSHMT) forms an internal aldimine linkage to PLP (not shown in Figure 
6). The pyridoxal ring of PLP and the side chain of His 126 of eSHMT are coplanar and 
stack on top of each other. THF binds close to PLP at the active site and its pteridine ring 
  
15 
 
lies parallel to the pyridoxal ring of PLP although not stacking on it directly. Carboxylate 
group of the product glycine bound as an external aldimine to PLP makes hydrogen bond 
interactions with Arg363. One of the oxygens of the carboxylate group of glycine also 
makes hydrogen bond interaction with Ser35 from the same subunit and with Tyr65 from 
the other subunit while the other oxygen interacts with His203 from the same subunit. 
Glu57 at the active site has been implicated to be important in the transfer of the formyl 
moiety to THF.
22, 37
  
It is generally accepted that SHMT achieves reaction specificity by maintaining a 
closed conformation of the active site during catalysis of L-Serine in the presence of 
THF, the physiological reaction catalyzed by SHMT. Nevertheless, the open structure 
accepts other β-hydroxy-amino acids for retro-aldol cleavage in the absence of THF. 
Racemization and transamination reaction also proceeds with the enzyme in the open 
conformation.
21, 22
  
A generally accepted mechanism for the retro-aldol reaction catalyzed by SHMT 
is illustrated below (Figure 7).
32-41
 Reaction is initiated after the substrate forms an 
external aldimine with the aldehyde group of PLP with the Cβ hydroxyl group of L-
Serine perpendicular and synperiplanar with the π-system of PLP.32 The N5 of THF seems 
to make direct nucleophilic attack on the Cβ carbon of bound L-Serine. A quinonoid 
intermediate is formed after the proton abstraction is complete which is detected at a 
wavelength of 490nm.
33
 This intermediate rearranges to the product bound PLP-external 
aldimine. This step involves a proton donor, B3H (in Figure 7) which saturates the Cα of 
the quinonoid intermediate. The identity of B3H has is not clear yet. The formaldehyde 
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released subsequently reacts with THF and Glu57 has been identified as B1H, the residue 
involved in the transfer.
22, 37
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Threonine aldolase does not participate in the one carbon transfer reactions as 
SHMT since L-TA does not bind THF. Kinetic studies by our collaborators at the 
University of Rome have provided us with a wealth of information about the substrate 
preferences for the two enzymes.
2
  Table 3 summarizes the results of comparative study 
between the two enzymes.            
 
 
 
 
 
                  
Figure 7: Schematic representation of proposed mechanism of conversion of L-
Serine to glycine in the presence of THF.
22
 
 
E-Quinonoid complex 
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As seen from the kinetic data in Table 3, SHMT is specific for L-serine cleavage 
whereas L-TA has preference for L-allo-threonine. Even though SHMT has different 
substrate specificity as compared to L-TA, it provides an excellent model for critical 
evaluation of L-TA and to evaluate the origin of reaction and substrate specificity in PLP-
dependent enzymes.  
1.3.4 E.coli L-TA (eTA) and Thermatoga maritima (TTA): 
The two most well characterized L-TAs are those from E. coli and T. maritima. 
The sequence identity between TTA and eTA is 24.1% and the alignment of the 
sequences is shown below in Figure 8.
42
 The TTA structure has already been solved.
43
 
TTA enzyme like eTA is a low specificity L-TA. The TTA structures show both internal 
as well as external aldimine formation (Figure 9, only internal aldimine is shown in the 
       
eTA 
   
eSHMT 
 
Reaction 
catalyzed  
kcat 
(min
-1
) 
Km (mM) kcat/Km 
(mM
-
1/min
-1
) 
kcat  
(min
-1
) 
Km (mM) kcat/Km  
(mM
-1
/
 
min
-1
) 
L-threonine 
cleavage 
62 10 6.2 4.3 43 0.1 
 
 
L-allo-
threonine 
cleavage 
376 0.19 1980 30 1.5 20 
 
 
 
L-serine 
cleavage 
1.(-) THF 
 
2.(+) THF 
 
 
 
1.9 
 
- 
 
 
16 
 
- 
 
 
0.11 
 
- 
 
 
ND 
 
640 
 
 
0.8 
 
0.3 
 
 
ND 
 
2130 
Table 3: Kinetic studies of eTA and eSHMT summarizing the substrate preference for 
either in a retroaldol cleavage reaction. L-Thr or L-allo-Thr cleavage is catalyzed by 
SHMT in the absence of THF.
2
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Figure) and also asymmetry in the substrate binding to different subunits of this 
tetrameric protein. Approximately 15
o
 rotation of the PLP ring is seen between the 
internal and external aldimine structures. Carboxylate group of the substrate bound to 
PLP as an external aldimine interacts with Arg171, Arg316 and Ser6. These residues are 
thought to hold the substrate in place. Also, His83 stacks on top of the PLP pyridoxal ring 
and hydrogen bonds to the substrate.  Another residue at the active site is His125, but has 
not been implicated in any mechanistic function.  
Another active site residue, Tyr87 has been suggested to be involved in ensuring 
preference for L-allo-threonine through hydrophobic interaction with the methyl group of 
the amino acid.
43
 Nevertheless, our analysis of the TTA structure did not show any close 
interaction between the L-allo-threonine and this hydrophobic residue. Even with low 
sequence similarity the TTA structure serves as a good model for determination and 
evaluation of eTA structure.  
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TTA MIDLRSDTVTKPTEEMRKAMAQAEVGDDVYGEDPTINELERLAAETFGKEAALFVPSGTM 60 
eTA MIDLRSDTVTRPSRAMLEAMMAAPVGDDVYGDDPTVNALQDYAAELSGKEAAIFLPTGTQ 60 
    **********:*:. * :**  * *******:***:* *:  ***  *****:*:*:**  
TTA GNQVSIMAHTQRGDEVILEADSHIFWYEVGAMAVLSGVMPHPVPGK-NGAMDPDDVRKAI 119 
eTA ANLVALLSHCERGEEYIVGQAAHNYLFEAGGAAVLGSIQPQPIDAAADGTLPLDKVAMKI 120 
    .* *::::* :**:* *:   :* : :*.*. ***..: *:*: .  :*::  *.*   * 
TTA RPRNIHFPRTSLIAIENTHNRSGGRVVPLENIKEICTIAKEHGINVHIDGARIFNASIAS 179 
eTA KPDDIHFARTKLLSLENTHN---GKVLPREYLKEAWEFTRKRNLALHVDGARIFNAVVAY 177 
    :* :***.**.*:::*****   *:*:* * :**   :::::.: :*:******** :*  
TTA GVPVKEYAGYADSVMFCLSKGLCAPVGSVVVGDRDFIERARKARKMLGGGMRQAGVLAAA 239 
eTA GCELKEITQYCDSFTICLSKGLGTPVGSLLVGNRDYIKRAIRWRKMTGGGMRQSGILAAA 237 
    *  :** : *.**. :****** :****::**:**:*:** : *** ******:*:**** 
TTA GIIALTKMVDRLKEDHENARFLALKLKEIGYSVNPEDVKTNMVILRTDNLKVNAHGFIEA 299 
eTA GMYALKNNVARLQEDHDNATWMAEQLREAGTDVMRQD--TNMLFVRVG--EENAAALGEY 293 
    *: **.: * **:***:** ::* :*:* * .*  :*  ***:::*..  : ** .: *  
TTA LRNSGVLANAVSDTEIRLVTHKDVSRNDIEEALNIFEKLFRKFS 343 
eTA MKARNVLINAS--PIVRLVTHLDVSRAQLAEVAAHWRAFLAR-- 333 
    ::  .** **   . :***** **** :: *.   :. :: :   
 
Figure 8: Sequence alignment diagram of eTA with TTA. The residues in bold are 
conserved in the active both the enzymes.
42
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This enzyme is thermophilic and the mechanism of catalysis may be different for 
the enzyme at elevated temperatures than that proposed at room temperature. 
Nevertheless, the enzyme served as a good candidate to further our understanding of the 
catalytic machinery which is similar to that for eTA.  
Figure 9: Shown above is the active site of native structure of Thermatoga maritima 
L-TA. Only internal aldimine formation is shown here. 
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1.4 Conclusion: 
Although, L-threonine aldolase does not contribute significantly to threonine 
metabolism, it has the potential to be an industrially important biocatalyst since good 
stereoselectivity is achieved during the single step L-TA catalyzed retro-aldol cleavage of 
glycine and assorted aldehydes at the laboratory scale. Immobilized and engineered 
enzymes would improve diasteroselectivity as well as synthetic activity of L-TA and 
make it industrially viable.  
L-TA being studied in our laboratory is obtained from Escherichia coli (eTA) and 
belongs to Fold Type I of the large family of PLP-dependent enzymes. It has selectivity 
towards retro-aldol cleavage of L-allo-threonine although other β-hydroxy amino acids 
may also act as substrates. eTA also catalyzes transamination and racemization reactions. 
The enzyme shows both substrate and reaction specificity. Elucidating the mechanism of 
the enzyme catalyzed reaction would aid in understanding how eTA achieves such 
stereoselectivity. Other closely related PLP-dependent enzymes like SHMT and L-TA 
from Thermatoga maritima are used for comparative analysis with eTA to develop a 
better appreciation of its reaction mechanism. Also, comprehension of the enzymatic 
reaction in greater details would help in developing the enzyme as a biocatalyst as well as 
establish an evolutionary relationship between the PLP-dependent enzymes of Fold Type 
I. 
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Specific Aim:  
Elucidate the reaction mechanism of Escherichia coli L-threonine aldolase using  
X-ray crystallography: 
Our objective is to use site-directed mutagenesis, enzyme kinetics and X-ray 
crystallography, as well as comparative analysis with other PLP-dependent enzymes that 
catalyze similar reactions as eTA to understand its catalytic mechanism at the molecular 
level. The specific aim of the current study is to elucidate the reaction mechanism of 
Escherichia coli L-threonine aldolase using X-ray crystallography. 
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CHAPTER 2 Structural Study of Escherichia coli L-threonine aldolase (eTA) 
2.1 Crystallography and its utility in establishing the reaction mechanism of eTA:  
Crystallography:  
X-ray crystallography is a well established tool in structural biology. Of around 
65,000 macromolecular structures deposited in the Protein Data Bank, more than 56,000 
have been determined using X-ray crystallography as the experimental method 
(http://www.pdb.org/pdb/search/advSearch.do). Development of high speed computers 
and crystallography related programs and the necessary software have made the job of a 
crystallographer much easier as compared to the early days of Max Perutz who won a 
Nobel prize for solving the structure of haemoglobin in 1962.
44
  
A brief description of macromolecular X-ray crystallography is provided here. In 
general, an object diffracts radiation whose wavelength is comparable to the size of the 
object.  Thus, X-rays whose wavelength is comparable to ultra small protein molecules 
serve as the radiation source to obtain images of these molecules. Also, since a single 
molecule does not diffract strongly enough to be detected, there is a need for a crystal 
composed of a wide array of ordered molecules oriented identically that diffract together 
to produce strong detectable reflections. A lens system to converge X-rays (as seen in a 
microscope where the radiation source is white light) is unavailable and readily 
interpretable images are not obtained directly. To circumvent this problem, computer 
simulated mathematical model of the protein is developed using a wide array of programs 
and related software.  
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In crystallography, information about the intensity as well as the phases of the 
recorded reflections is needed for structure determination. The intensity of individual 
reflections is obtained directly from the diffraction patterns recorded on the detectors. 
The phase information is a little more difficult to obtain. Isomorphous Replacement 
(Heavy atom replacement), Anomalous Scattering and Molecular Replacement are 
employed to solve the phase problem. In Isomorphous Replacement, a heavy atom (eg: 
selenium) is introduced into the protein and the positions of the atoms of the protein are 
calculated based on the diffraction by the heavy atom. In Anomalous Scattering, the 
property of heavy atoms to absorb X-rays of specific wavelengths is taken advantage of 
and the positions of atoms of the protein are then determined based on the positions of the 
heavy atoms.  Molecular replacement is used when the unknown structure of a protein is 
solved using the known structure of a similar protein.
45
 
Crystallography in determining the mechanism of eTA: 
Since crystallography provides a molecular picture of the protein with a wealth of 
information about the active site we explored structural studies with X-ray 
crystallography to understand the catalytic mechanism of eTA. We have used the 
structures of eTA in its native form as well as bound to its substrate(s) to draw inferences 
about the differences at the active site, if any in the presence and absence of ligands and 
understand the mechanism of the enzyme at the molecular level. 
Obtaining ligand bound crystals: 
Protein crystals contain more than 50% solvent and readily allow the diffusion of 
ligands (substrate or product) to reach the active site.  Co-crystallization of protein and 
ligand is extensively used to obtain crystals with substrate or product bound. Another 
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technique frequently employed to achieve crystals with bound ligands is soaking the 
native crystals in a buffer with a predetermined concentration of the ligand. This 
technique is simple but not very elegant in that the crystal may dissolve, become 
disorganized and/or lose its diffraction ability.
46, 47
 Another approach is to use a cryo-
protectant with a predetermined concentration of the ligand. Cryo-protectants are used to 
protect the crystal from degrading when impinged by high intensity X-rays. Cryo-
protectants are employed just prior to setting the crystal in X-ray beam and can readily 
aid in penetration of the ligand to the active site prior to data collection.
48
 Yet another 
technique used to obtain ligand bound crystals is to synthesize the substrate bound to the 
active site of an enzyme from a crystal containing its product if the enzyme catalyzes a 
reversible reaction.
43
 We have used co-crystallization to obtain eTA bound to different 
substrates and have solved structures of eTA with product as well as substrate bound.   
There is only one other L-TA structure from Thermatoga maritima deposited in 
the Protein Data Bank in the native form as well as bound to the substrate.  
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2.2 Purification, Crystallization, Data Collection and Structure Determination of 
eTA: 
Clone of Escherichia coli L-threonine aldolase (eTA, molecular weight per 
monomer is 36,500 Dalton) was provided by our collaborators. Expression and 
purification of eTA was carried out using a procedure developed by our collaborators in 
University of Rome
4
 but slightly modified to suit our laboratory set up. 
2.2.1 Purification of E.coli L-TA (eTA):  
HMS174 cells transformed with L-threonine aldolase (from Escherichia coli) 
over expressing pET22 plasmid was used to grow an overnight culture (300mL). The 
culture was inoculated (1:20) into 6L of Luria-Bertani broth (non-buffered, containing 
100mg/mL ampicillin and 30mg/mL pyridoxal 5’-phosphate). Bacteria were grown at 370 
C under aerobic conditions until the OD600 reached 0.5. The cells were induced with 
0.05mM isopropyl-thio-β-D-galactosidase (IPTG) to express eTA. Bacteria were 
harvested after 20hrs. Cells were suspended in a buffer containing 10mM Tris/HCl (pH 
7.6), 1mM NaCl and 1mM EDTA and cell lysis was carried out in Avestin French Press 
followed by centrifugation at 12,000 rpm for 20 mins. Streptomycin sulfate (10 g/L) was 
added to the supernatant in order to precipitate DNA. The cell extract was centrifuged at 
12,000 rpm for 20 mins. , the pellet discarded while ammonium sulfate was added to the 
supernatant to a final concentration of 313 g/L (50% saturation). The solution was 
centrifuged at 12,000 rpm for 20 mins. and ammonium sulfate was added to the 
supernatant to 75% saturation (176 g/L). After centrifugation, the precipitant was 
dissolved in 20mM Potassium Phosphate buffer pH7.5 which was dialyzed against the 
same buffer with an overnight dialysis change of 1L. The diasylate was centrifuged and 
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the supernatant was loaded onto DEAE-Sepahdex column (5 x 15 cm.) which was 
equilibrated with 20 mm potassium phosphate.  100 mL of the equilibration buffer was 
used to wash the column. Elution was carried out with a 1L linear gradient of 20mM 
potassium phosphate pH 7.5 with increasing salt concentration up to 0.4M NaCl. 
Fractions with highest A420/A280 were pooled and precipitated by ammonium sulfate 
addition to 75% saturation followed by centrifugation. The pellet was dissolved in 50mM 
potassium phosphate pH 7.0 and was loaded onto phenyl-Sepharose (3 x 12 cm.) The 
column was pre-equilibrated with 50 mM potassium phosphate containing 176 g/L 
ammonium sulfate. The elution buffer was a 600mL linear gradient of equilibration 
buffer and 20mM potassium phosphate pH 7.0 with no salt. Fractions of highest purity as 
judged by single band on SDS-page gel (Figure 10) were pooled and concentrated with 
75% ammonium sulfate. Following centrifugation, the pellets were stored at -20
0
C and 
dialyzed just prior to crystallization.  
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2.2.2. Crystallization of native as well as ligand bound eTA: 
Protein Quantification, Purity and Activity:  
Pure and homogenous protein solution is a pre-requisite for successful 
crystallization. Thus, eTA was dialyzed in 20mM potassium phosphate and its purity was 
checked using SDS-Page gel electrophoresis. The enzyme was found to be 90% pure. 
Shown below are the pictures of the SDS-page gel before as well as after purification 
(Figure 11).  
 
 
Figure 10: SDS polyacrylamide gel with each lane showing the different 
fractions of eTA collected after purification with Phenyl-Sepharose 
column. These fractions were pooled together and the protein was 
precipitated with ammonium sulfate. The final dialysis was carried out in 
20mM Potassium Phosphate pH 7.0. 
Mol. Wgt. 
36,500 D 
Dalton 
Protein marker 
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To ensure that the enzyme is stable and functional, the enzyme activity was 
determined prior to crystallization. The activity of the enzyme dialyzed against 20mM 
potassium phosphate was determined as per the previously reported procedure for 
SHMT.
49
   
eTA activity: L-allo-threonine which is a substrate for eTA undergoes retro-aldol 
cleavage in the presence of enzyme. The enzyme alcohol dehydrogenase also present in 
the reaction mixture converts the product of the retro-aldol cleavage reaction, 
acetaldehyde to ethanol in turn converting NADH into NAD
+
. The decrease in 
absorbance at 340nm corresponding to the conversion of NADH to NAD
+ 
is followed and 
Figure 11: SDS polyacrylamide gel showing a fraction before 
purification with Phenyl-Sepharose column (Lane B) and after 
purification with Phenyl-Sepharose column followed by final dialysis in 
20mM Potassium Phosphate pH 7.0 (Lane A) 
 
Protein marker 
Mol. Wgt. 
36,500 D 
Dalton 
Lane A Lane B 
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thus activity of eTA is determined. Table 4 shows the observed activity for the purified 
eTA. 
 
Enzyme  
(10mg/mL) 
ADH (3mg/mL) + 
NADH(6 mg/mL) 
L-allo-
threonine 
(50mM) 
Buffer ( Na-
BES pH 7.4) 
Rate (min
-1
) 
20 μL 30 μL 50 μL 900 μL -2.104 
 
Crystallization Experiment: 
The enzyme was dialyzed against 20mM potassium phosphate pH 7.0. Following dialysis 
the enzyme was quantified using the relation; 
1AU = 0.983 mg/mL 
Molar concentration was calculated using; 
13mg/mL = 90 μM (90% pure) 
Crystallization Buffer:  The enzyme (eTA) was screened against the crystallization buffer 
conditions in Screen I (40 conditions) and Screen II (40 conditions) provided in the 
Crystal Screen Macromolecular Crystallization kit by Hampton Research. Each of the 
conditions is composed of a precipitant in a buffer with or without the presence of a salt. 
Crystallization:  Both ‘hanging drop’ and ‘sitting drop’ vapor diffusion methods were 
attempted. Hanging drop method provided better results. A schematic representation of 
the ‘hanging drop’ method is provided below (Figure 12). 
Table 4: Table shows the rate measurement for the activity assay performed for eTA  
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The reservoir contains the precipitant (550μL) while each drop is comprised of a 
mixture of protein and precipitant.  Several combinations of protein (22mg/mL, 154μM 
or 10mg/mL, 70μM) to crystallization buffer ratios were used in the drop of which 1:1 
ratios provided better crystals. Schematic representation of a crystallization set up is 
shown in Figure 12.  In one drop 2μL of protein of concentration 22mg/mL (154μM) was 
mixed with 2μL of the crystallization buffer while in the other drop 2μL of protein of 
concentration 10 mg/mL (70μM) was mixed with 2μL of the crystallization buffer 
(Figure 13). To obtain product or substrate bound crystals, protein was equilibrated with 
the amino acid substrates (L-Thr and L-Ser) just prior to crystallization. The ligand 
concentration was between 6-30 mM. 
 
 
 
 
 
Figure 12: Schematic representation of Hanging Drop vapor diffusion method 
for protein crystallization. The schematic is reproduced from Qiagen handbook 
for Protein crystallization.  The drop on the cover slip contains the protein and 
precipitant, while the reservoir solution contains the precipitant. 
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                                                         Cover slip 
 
 
 
The crystallization conditions that provided single diffractable crystals are 
summarized in the results section (Section 2.3.1). Crystals were obtained for native eTA 
as well as eTA with L-Ser at pH 5.6 (eTA/ Ser5.6), eTA with L-Ser at pH 7.5 (eTA/ 
Ser7.5) and eTA with L-Thr at pH 7.5 (eTA/ Thr7.5).  
2.2.3 Data Collection:  
The general procedure followed for data collection of each of the four crystals 
mentioned above (native eTA; eTA/ Ser5.6; eTA/ Ser7.5; eTA/ Thr7.5) was similar with 
minor modifications. The crystals were cryo-protected, and flash cooled in a nitrogen 
stream. For three of the four crystals the crystallization buffer contained PEG 400 which 
served as a cryo-protectant whereas 5uL of 100% glycerol was needed for protecting the 
fifth one (see table Table 5 for details about the data collection protocol).  
Diffraction data was collected for the cryo-protected crystals at 100K using a 
Molecular Structure Corporation (MSC) X-Stream Cryogenic Crystal Cooler, a Rigaku 
IV ++ image plate detector, and a Rigaku MicroMax-007 X-Ray source (copper) fitted 
with MSC Varimax Confocal optics operating at 40 kV and 20 mA. Collection of 
2μL of 154 μM 
protein + 2μL of the 
crystallization 
buffer 
2μL of 154 μM 
protein + 2μL of the 
crystallization 
buffer 
Figure 13: Schematic representation of a crystallization set up.  
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redundant data was imperative since all the crystals obtained were thin and flat and data 
was lost when the plane of the crystals were aligned parallel to the X-ray beam.  
 
Initial Indexing: 
Initial still frames were indexed for each of the four crystals to determine their 
respective space groups and unit cell dimensions. The space groups and the unit cell 
dimensions were then used to decide the number of oscillation frames to be collected as 
well as the crystal-detector distance. Three of the crystals (native, eTA/ Ser7.5 and eTA/ 
Thr7.5) indicated an orthorhombic space group requiring a minimum data of 90
0
. On an 
average 240 oscillation frames were collected from φ 00 to 120 0 at 0.50 intervals for each 
of the three crystals. The crystal of eTA/ Ser5.6 complex indicated a monoclinic cell 
requiring a minimum data of 180
0
. 380 oscillations frames (0-190
0
)
 
were collected for 
this crystal to ensure adequate data for scaling and averaging. The data collection 
protocol is summarized in Table 5.  
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Parameter Native  
(pH 7.5) 
eTA/ Ser5.6 eTA/ Ser7.5 eTA/ Thr7.5 
Resolution (Å) 2.3 2.3 2.2 2.3 
 
Crystal to detector 
distance  
150mm 110mm 150mm 150mm 
 
 
Exposure time  6 mins. 6 mins. 6 mins.  6 mins. 
 
Start to end angle 0
0
 to 120 
0
 0
0
 to 190 
0
 0
0
 to 120 
0
 0
0
 to 120 
0
 
 
Cryo-protectant Mother 
liquor 
40 μL Mother 
liquor + 5μL 
100% glycerol 
Mother 
liquor 
Mother liquor  
 
Data reduction: 
The diffraction data were processed using the using the d
*
trek program in the 
CrystalClear software package provided by Rigaku Americas Co. and the CCP4 suite.
50
 
Statistics are listed in Table 6. 
 
 
 
 
 
 
Table 5: Data Collection protocol for each of the four crystals is summarized in this 
table. 
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 Parameter Native crystal    
(pH 7.5) 
eTA/ Ser 5.6 eTA/ Ser7.5   eTA/ Thr7.5 
 
Space group  C2221  P21 
 
C2221 
 
C2221 
 
Unit cell 
parameters  
(a, b, c) Å 
76.6,100.8, 
175.6  
 
 77.2,104.1,  
84.9 
 
 77.1,101, 
176.6  
 
74.4, 101, 
 176.1  
Resolution range 
(Å) 
38.32-2.3 
(2.38-2.3) 
 34.46-2.3 
(2.38-2.3) 
29.16-2.2  
(2.28-2.2) 
29.34-2.3     
(2.38-2.3) 
Total number of 
observed 
reflections 
320884  204371 99927 132270 
 
Unique 
reflections 
28335  59351 30725 28720 
 
Completeness 
overall/outer 
shell (%) 
92.3% (88%) 99% (97.7%) 86.8% (90.7%) 93.6% (94.2%) 
 
     
Rmerge (%) 10.4 (28.8) 
 
13.7 (35) 
 
8.5 (24.7)  
 
9 (23.3) 
 
Cell Volume 
(cubic Å) 
1358075.612 685323.7 1376069.7 1357834.8 
 
Average I/σ(I) 16.9 (8.7)  
 
10.2 (4.6) 7 (3.4) 
  
 
11.8 (5.8)  
 
Mean 
redundancy  
11.32 (11.59) 3.44 (3.34) 3.25 (3.5)  4.61 (4.58) 
Rmerge = ∑| I – {I}|/∑ (I), where I is the observed intensity and {I} is the weighted mean 
of the reflection intensity. The values in parentheses are for the highest resolution shell 
Matthew’s Co-efficient 51 (M.C):  
Table 6: Data collection and reduction statistics. 
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Matthew’s Co-efficient is calculated to determine the solvent content in a protein 
structure. A solvent content of 30-70% with the corresponding number of molecules 
indicated in the asymmetric unit is acceptable. 
M.C was determined for the native eTA structure as well as eTA/ Ser5.6 complex 
and the solvent content was found to be 47% for both the structures and indicated two 
and four molecules in the asymmetric unit, respectively. Since the co-crystals with L-Ser 
and L-Thr at pH 7.5 had the same cell parameters as the native eTA their respective 
asymmetric unit was also concluded to contain two molecules.  
 
2.2.4 Structure Determination:  
Native eTA (C2221):  
Structure solution with Molecular Replacement:  
The structure determination of the native eTA was carried out using the WEB-
based molecular replacement program, CaspR.
52
 The structure of L-TA from 
Thermatoga maritima (PDB code 1LW5, 24.1% sequence identity to eTA) was used as a 
search model to carry out the molecular replacement. Multiple structure sequence 
alignment was carried out with T-coffee in CaspR
52
 followed by homology model 
building with MODELLER. Out of 15 models generated one model gave the best 
solution (correlation coefficient of 26%, R-factor of 53.4%) which was subsequently 
refined using the CNS (Crystallographic and NMR Systems).  
The final model obtained from CNS in CaspR
52
 did not have the sequence of 
eTA. The program Phenix (Python-based Hierarchical ENvironment for Integrated 
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Xtallography)
53 
was used to autobuild the eTA sequence into the electron density map of 
the solved model.  The output model from Phenix
53
 was used for further refinement. 
Phenix is a software suite for automated determination of protein structures.  
Structure Refinement with CNS 1.2
54
: CNS is a software suite used for structure 
determination, in particular, structure refinement. The starting model obtained from 
Phenix
53
 was subjected to alternate rigid body refinement, gradient minimization 
followed by simulated annealing using CNS 1.2.
54
Simulated annealing was performed to 
remove any phase bias that might have been introduced from molecular replacement. The 
model was manually corrected using COOT 0.5.2
55
 and TOM.
56
 Almost all the residues 
were well defined in the electron density maps after the first refinement itself except for a 
loop of five residues from 284 to 288 and a loop of three residues from 136 to 138. These 
recurrently appeared in the Ramachandran plot (generated using PROCHECK
57
) as 
outliers. The model was corrected with subsequent refinements. After several cycles of 
refinement with CNS 1.2
54
, manual model correction and water additions were done 
using COOT 0.5.2
55
 and TOM
56
,
 
the current Rwork/ Rfree for the native eTA structure is 
24.5(%)/ 31(%). Further refinement with model correction and addition of water and 
other ligands are ongoing.  
 
 
eTA/ Ser5.6 complex (P21): 
Structure solution using molecular replacement and refinement: The refined native eTA 
structure was used to solve for the eTA/ L-serine complex at pH 5.6 (space group, P21). 
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Using AMoRe (an automated package for molecular replacement)
58
, a single solution 
was obtained with correlation co-efficient of 26% and R-factor of 53.4%.  
The model was subjected to rigid body refinement followed by alternate 
minimization and simulated annealing using CNS 1.2.
54
 Manual model correction was 
done using COOT 0.5.2
55
 and TOM.
56
   After several cycles of refinement with CNS 
1.2
54
 and model correction (especially for the loop of residues described in native eTA 
structure) above and water addition using COOT 0.5.2
55
 and TOM
56
, the current Rwork/ 
Rfree is 24.8(%)/ 30.6(%).  Further refinement with model correction and addition of 
water and other ligands are ongoing. 
eTA/ Ser7.5 complex (C2221): 
Structure determination and refinement: Since eTA/ Ser7.5 complex is isomorphous with 
native eTA structure with same space group, C2221 and similar cell parameters, the 
refined model of native eTA structure was used as an input model for refinement of the 
complex using CNS 1.2.
54
 After several cycles of alternate refinements, including rigid 
body, minimization and simulated annealing, addition of water and other ligands, and 
intermittently correcting the model manually with COOT 0.5.2
55
 and/or TOM
56
, the 
current Rwork/ Rfree is 26(%)/ 30.6(%). Further refinement with model correction and 
addition of water and other ligands are ongoing. 
eTA/ Thr7.5 complex (C2221): 
Structure determination and refinement: Structure determination was performed as 
described for eTA/ Ser7.5 complex since this complex is also isomorphous with the 
native structure. The model was subjected to several cycles of refinement with CNS 1.2
54
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and model correction (especially for the loop of residues described in native eTA 
structure above) and water addition using COOT 0.5.2
55
 and TOM
56
 with the final Rwork/ 
Rfree 20.33(%)/ 25(%)    
Refined model statistics for eTA/ Thr7.5 complex, as well as each of the other 
crystals is summarized in Table 7. The root mean square deviations for the bond angles 
and bond lengths as well as the average B-factors for protein, ligands and water are also 
provided in Table 7.  
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 Native 
eTA 
eTA/ Ser5.6 eTA/ Ser7.5 eTA/ Thr7.5  
Rwork 
(95% data) 
24.5 24.8  26 20.33 
 
 
Rfree 
(5% data) 
31 30.6 30.6 25.5 
     
Rmsd standard 
Geometry: 
 
Bond Length (Å) 
 
Bond Angle (
0
) 
 
 
 
0.007 
 
1.3 
 
 
 
0.006 
 
1.3 
 
 
 
0.007 
 
1.3 
 
 
 
0.006 
 
1.4 
Average B factor  
 
(i)  Non -hydrogen 
atoms 
 
 
 
25.5 
 
 
25.1 
 
 
28.5 
 
 
21.9 
(ii) Protein  25.5 24.8 
 
28.4 21.4 
(iii) Water 26.4 26.4 29.5 26 
(iv) Cation (Mg
2+
,       
Ca
2+
, Na
+
) 
22.7 19.5 34.8 14.9 
(v)PLP 
 
     PLG 
 
     PLT 
23.5 
 
- 
 
- 
25.5 
 
- 
 
- 
- 
 
36.2 
 
- 
- 
 
- 
 
24.7 
(vi) Ligands: 
 
L-Ser 
 
 
 
 
Nil 
 
 
37.9 
 
 
Nil 
 
 
Nil 
Rwork = ∑||Fo| - |Fc||/∑|Fo|, where Fo and Fc are the observed and calculated structure factor 
amplitudes, respectively. Rfree is the crystallographic Rwork calculated with 5% of the data 
that were excluded from the structure refinement. PLT is L-Thr bound to PLP as an 
external aldimine. PLG is glycine bound to PLP as an external aldimine.  
 
 
Table 7: Refined model statistics for each of the four crystals is summarized in this 
table. 
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Validation:  
The Ramachandran plot was also checked at the later stages of the refinement to 
inspect for unrealistic conformations in the models. The residues that occur in the 
generously allowed as well as disallowed regions of the plot are shown for each of the 
structures in red font (Figures 14-17) and Ramachandran plot statistics are summarized in 
Table 8.  
 
 Native 
eTA 
eTA/ Ser5.6  
 
eTA/ Ser7.5 
 
eTA/ Thr7.5  
Residues in the most 
favored region 
 
89.1% 91.1% 88.6% 90.6% 
Residues in 
additionally allowed 
region 
9.7% 
 
 
 
8% 10.2% 8.3% 
Residues in 
generously allowed 
region  
 
Residues in 
disallowed region  
 
1% 
 
 
 
0.2% 
 
0.6% 
 
 
 
0.3% 
 
1% 
 
 
 
0.2% 
 
1.1% 
 
 
 
0.0% 
     
 
For each of the structures the residues that occur in the disallowed regions of the 
plot were checked in their respective electron-density maps. These residues seem to recur 
in the Ramachandran plot since they appear disordered in the maps.  
 
 
 
Table 8: Ramachandran plot statistics for all the four structures are presented here.  
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Figure 14: Ramachandran plot of refined structure of native eTA. The 
plot was generated using PROCHECK.
57
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Figure 15: Ramachandran plot of refined structure of eTA/ Ser5.6 
complex. The plot was generated using PROCHECK.
57
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Figure 16: Ramachandran plot of refined structure of eTA/ Ser7.5 
complex. The plot was generated using PROCHECK.
57
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Figure 17: Ramachandran plot of refined structure of eTA/ Thr7.5 
complex. The plot was generated using PROCHECK.
57 
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2.3 Results and Discussion: 
2.3.1 Crystallization:  
Initial Crystallization: Initial crystals were obtained in some of the conditions provided in 
the Crystal Screen Macromolecular Crystallization kit (Screen I and II) by Hampton 
Research for native eTA as well as eTA bound with ligands. The conditions are 
summarized in the tables below (Table 9 and Table 10).  
The protein concentration in each of the conditions was either 10 mg/mL or 22mg/mL. 
The ligand concentration is between 6-30mM. Crystallization was carried out at room 
temperature. All the crystals obtained were flat and very thin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
47 
 
 
 
                              Crystallization Condition  
Observation 
(after 7 days) 
Salt       Buffer Precipitant Ligand 
A) 0.2M 
ammonium 
sulfate 
0.1M sodium 
cacodylate  
pH 6.5 
30% w/v PEG 
8000 
Nil  
 
 
 
B) 0.2M 
magnesium 
chloride 
hexahydrate 
0.1M HEPES  
pH 7.5  
 
30% PEG 400 
Nil 
Or 
L-Thr 
 
 
C) 0.2M 
Calcium chloride 
hexahydrate 
0.1M HEPES  
pH 7.5 
28% PEG 400 L-Ser 
 
 
 
D) None 0.1M HEPES  
pH 7.5 
0.8M sodium 
phosphate 
monobasic 
monohydrate 
Nil  
E) None 0.1M HEPES 
 pH 7.5  
1.4M sodium 
citrate tribasic 
dihydrate 
Nil  
 
 
 
F) None  0.1M sodium 
citrate tribasic 
dehydrate 
pH 5.6 
20% v/v 2-
propanol 
20% w/v PEG 
4000 
 
L-Ser 
(6.25mM) 
 
 
 
       
      Clear drop  
 
            
 Flat plate crystals 
 
 
Flat plate crystals 
    Spherical    
agglomerate 
 
 
     Salt crystal 
 
  
        
Flat, plate crystals  
 
 
        
Flat, plate crystals  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9: Conditions from Screen I that provided crystals for native eTA and eTA 
bound to ligands is summarized here. 
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                 Crystallization Condition  
 Observation (after 7 
days) 
Salt      Buffer Precipitant 
A) 2M ammonium 
sulfate 
     None  5% v/v 2-propanol 
 
 
B) 0.01M zinc     
sulfate 
heptahydrate 
 
0.1M MES 
 pH 6.5  
25% v/v PEG 
monoethylene 
ether 550 
C) None 0.1M HEPES 
 pH 7.5 
20% w/v PEG 
10,000 
 
 
 
 
 
Spherical agglomerate  
 
    
    Needle Cluster 
 
 
 
   Flat plate crystals 
 
 
 
The initial crystals obtained with eTA (10mg/mL) in condition C) [0.2M calcium 
chloride hexahydrate in 0.1M HEPES pH 7.5 with 28% PEG 400 and L-Serine (2mM)] 
and condition F) [0.1M sodium citrate tribasic dehydrate pH 5.6 with 20% v/v 2-propanol 
20% w/v PEG 4000 and L-Serine (6.25mM)] from Screen I (Table 9) were single and of 
diffraction quality. Although, the ligand in both the crystals was L-Serine, the pH at 
which the crystals were obtained was different. In condition C) the pH was 7.5 while in 
condition F) the pH was 5.6. This difference in pH of crystallization buffer has 
consequences in our interpretation of the structures as well as the mechanism that is 
ultimately proposed.  
Single crystals were also obtained with eTA (17.5mg/mL) in condition B) [0.2M 
magnesium chloride hexahydrate in 0.1M HEPES pH 7.5 with 30% PEG 400] from 
Screen I (Table 9) in the presence of L-Threonine (28mM) as the substrate and were used 
for data collection.  
Table 10: Conditions from Screen II that provided crystals for native eTA and eTA 
bound to ligands is summarized here 
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The initial crystal obtained with eTA (22mg/mL) in the absence of any ligand in 
condition B) [0.2M magnesium chloride hexahydrate in 0.1M HEPES pH 7.5 with 30% 
PEG 400] from Screen I (Table 9) was not single and hence, optimization of the 
conditions was required.  
Optimization of conditions: Since condition B) from Screen I provided twinned crystals 
in the absence of a ligand, optimization of the condition was necessary. Addition of 5% 
glycerol to the reservoir solution of condition B) to slow down nucleation only resulted in 
a thin film formation and did not aid the formation of single crystals. Small amount of a 
detergent (n-octyl-β-D-glucoside) was added to prevent agglomeration and hence aid 
single crystal formation. Although a few single crystals were obtained on addition of the 
detergent, the crystals were not diffractable. PEG 400 concentration was also varied 
between 25-30% for condition B). Use of 25% PEG 400 in condition B) instead of 30% 
with fresh protein (10mg/mL) resulted in single crystals of diffraction quality.  
Final crystallization conditions that provided single native as well as ligand bound 
crystals are summarized in Table 11. 
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                              Crystallization Condition  
 
Observation  
(after 7days) 
Salt  Buffer Precipitant Substrate 
 
I)  0.2M 
Calcium 
chloride 
hexahydrate 
 
0.1M HEPES 
 pH 7.5 
    
 28% PEG 
400 
  
L-Ser 
 
     
 
   
 
II) None  0.1M sodium 
citrate tribasic 
dehydrate  
pH 5.6 
20% v/v 2-
propanol 
20% w/v PEG 
4000 
L-Ser 
 
 
 
 
 
III) 0.2M 
magnesium 
chloride 
hexahydrate 
0.1M HEPES  
pH 7.5 
25% PEG 400 Nil  
 
 
 
 
 
IV) 0.2M 
magnesium 
chloride 
hexahydrate 
0.1M HEPES  
pH 7.5 
30% PEG 400 L-Thr  Nil 
     
 
    
Flat, single plate  
crystals 
 
 
Flat, single plate 
 crystals 
 
 
 
 
Flat, single plate  
crystals 
 
 
 
 
 
2.3.2. Overall Structural Description:  
eTA has been established as a tetrameric protein in solution
59
. It binds one PLP 
molecule per monomer. In the structures reported here, two of the monomers form an 
intimate tight catalytic dimer. As with other Fold-type I enzymes , residues from both the 
monomers form the active site and each monomer consists of a large domain with seven 
Table 11: Final conditions that provided single crystals are summarized here. The protein 
concentration used in conditions I, II and III is 10mg/mL while in condition IV the protein 
concentration is 17.5mg/mL. The protein to crystallization buffer ration in all the cases is 
1:1 
Flat, single plate 
crystals  
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β-strand structures flanked by α-helices and a small domain composed of three β-strand 
sheet structures with interlinking α-helices.   
The eTA structures show PLP at the active site either as an internal aldimine 
bound to the conserved Lysine residue of the active site (covalent bond between C4’ of 
PLP with amide N1 of Lys197) or as an external aldimine linked to the substrate or the 
product (covalent bond between C4’ of PLP with amide N of a β-hydroxy amino acid). 
The pyridoxal ring of PLP rotates by ~20
0
 between the internal and external aldimine 
form.  
Monovalent or divalent cation, whichever is present in the crystallization buffer 
(Na
+1
, Ca
+2
 or Mg
+2
) is seen close to the active site. But these are not suggested to be 
involved in catalysis
43
, but possibly in maintaining the structure of the active site. Each of 
these ions readily form an octahedral coordination sphere flanked by the residues Thr8, 
Thr10, Ser196, Thr201 and Gln230 with a water molecule in close proximity in all the 
structures. Well coordinated ions are also present at the dimer interface to stabilize the 
quaternary structure.
43
 Detailed description of native as well as ligand bound structures is 
provided hereunder; 
 
Structural details of native eTA: 
Although eTA is a tetrameric protein, the asymmetric unit of native eTA shows 
the presence of a dimer (Figure 18). The tetramer can be generated using symmetry 
operators. A divalent cation (Mg
+2
) is located between the large and the small domains. 
Twenty nine residues from monomer A interact with 31 residues of monomer D.
60 
The 
dimer buries a total area of 3990 Å
2
 at the A/D interface.
60
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Each of the two molecules of PLP (related by non-crystallographic symmetry) are 
located at the interface of the large and small domains of individual monomeric unit to 
make a Schiff-base with Lys197 forming an internal aldimine (Figure 18).  
Nevertheless, a loop of about ten residues from the opposite monomer (from Lys121 to 
Lys131) wraps around the active site to position His126 in such a way that it has access 
to the active site (Figure 18). The position of His126 is well defined in the native 
structure. 
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Figure 19 shows the active site of native eTA structure with the residues that 
interact with PLP. His83 stacks parallel on top of the PLP ring from the re face while 
Ala168 is present at the si face (His83 and Ala168 are not shown in Figure 19). The PLP 
is recognized via hydrogen bond interactions between its phenolic group (O3) and the 
guanidinium group of Arg169, and its pyridine nitrogen (N1) with the side chain of 
Asp166. The position of Asp166 is maintained by hydrogen bond interaction with Asn62.  
Other residues that recognize the PLP phosphates via hydrogen bond interactions are the 
Figure 18:  The catalytic dimer is represented here. The two monomers have 
been depicted in green and blue ribbons. Mg
+2
 ions (yellow) at the interface of 
the small and the large domain; PLP (magenta) bound to Lys197 with a loop 
(red) of about ten residues from the other monomer wrapping around the active 
site.  
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amide nitrogen of Gly58 and hydroxyl group of Thr59, as well as water-mediated 
hydrogen bond interactions with the protein. The residues Arg169, Asp166, Asn62, 
Glu58 and Thr59 are conserved in L-TAs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 shows the active site of native eTA with the residues other than those 
involved in PLP recognition. Arg308 makes close hydrogen-bond interactions with two 
water molecules via its guanidinium groups. Other residues including His83, His126, 
Glu88 and Phe87 have been implicated in the catalytic function of eTA and are shown in 
Figure 20.  
 
Figure 19: Active site of native eTA showing the residues interact with PLP. These 
residues are conserved amongst various L-TAs as well as other PLP-dependent 
enzymes.  
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Structural details of eTA in complex with L-Serine at pH 5.6 (eTA/ Ser5.6): 
The complex between eTA and L-Ser was crystallized at a pH of 5.6 which is 
much lower than pH 7.4 at which physiologically relevant reactions are carried out in the 
cell. At pH 5.6, the catalytic activity of the enzyme is reduced almost by 10-fold
4
. To 
understand the molecular basis for the reduced enzymatic activity at pH 5.6 we co-
crystallized the protein with L-Ser. 
Unlike the native structure, this complex crystallized with a tetramer in the 
asymmetric unit (Figure 21). Each monomer binds a molecule of PLP through internal 
aldimine formation, similar to the native/ eTA structure. As with the native structure, we 
observe ions (Na
+
instead of Mg
+2 
in native eTA structure since the former was used in the 
Figure 20: Active site of native eTA structure. The active site residues as well as the 
two well co-ordinated water molecules are shown. 
  
56 
 
crystallization) close to the active site, and also at the inter-dimer interface (Figure 
21).The four subunits are denoted A-D. The A/D (or B/C) is the catalytic dimer (distance 
between N1-N1 of PLP in A/D is 34Å) while A/C (or B/D) is less intimate (N1-N1 
distance of 45Å).  
The tertiary structure of the complex is very similar to the native structure with 
root mean square deviation (rmsd) of 0.3Å. Nevertheless, subtle changes in the active site 
are evident on examination of the structure.  
The residues Asp166, Arg169, Gly58 and Thr59 (these residues are not shown in 
Figure 22) make hydrogen bond interactions with various atoms of PLP similar to that 
described above for the native eTA structure. PLP is bound to Lys197 as an internal 
aldimine (Figure 22). Interestingly, co-crystallization of the ligand L-Ser at pH 5.6 has 
resulted in the substrate being trapped at the active site. The amide nitrogen of L-Ser is 
about 3.3Å away from the C4’ of PLP suggesting absence of any external aldimine 
formation. Consistently, we do not observe presence of product glycine. Although the 
ligand density is very strong in all four subunits, it is disordered into several orientations 
especially in two of the subunits (A and C). Thus, the structure shows asymmetry in 
binding. 
  The carboxylate of L-Ser makes hydrogen-bond interactions with the 
guanidinium groups of Arg308 and Arg169, as well as the hydroxyl of Ser6. The two 
water molecules that were found to hydrogen-bond to the guanidinium group of  Arg308 
(Figure 22) in the native structure are now absent in this structure because the carboxylate 
group of L-Ser replaces the two water molecules. The carboxylate group also makes close 
hydrogen bond interactions with the guanidinium group of Arg169. The hydroxyl group 
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of L-Ser makes hydrogen bond interactions with the side chains of both His83 and 
His126, the interaction with the latter being stronger. His126 is well defined in the 
electron density map.  
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Figure 21: Tetrameric eTA/ L-serine complex at pH 5.6 is shown here. Sodium ions 
(blue) and PLP molecules (yellow) and the catalytic dimers A/D (cyan) and B/C (red) 
are also depicted here.  
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Structural details of eTA in complex with L-Serine at pH 7.5 (eTA/ Ser7.5): 
We have also studied the complex structure between eTA and L-Ser at 
physiological pH of 7.5, where the enzyme shows optimum activity. The eTA/ Ser7.5 
complex structure is isomorphous to the native structure, crystallizing with a dimer in the 
asymmetric unit. The rmsd between the two structures is 0.2Å, suggesting similar 
conformation. As with the native eTA structure, cations (Ca
+2
 instead of Mg
+2
 in native 
eTA structure) are present at the interdomain interface of each monomer.  
As shown in Figure 23, eTA/ Ser7.5 also shows bound PLP at the active site, 
making similar protein interactions as described for the structures above. Also, the PLP 
Figure 22: Shown above is the active site of eTA/ L-Serine complex at pH 5.6. L-
serine (SEN) is shown trapped at the active site. The carboxylate group of SEN 
displaces the two well co-ordinated water molecules seen in the native structure. Not 
all residues, including Ser6, Asp166, Arg169, Glu58, Thr59 and Arg229 described in 
the text are shown here. 
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essentially makes an aldimine linkage with product Gly (i.e. an external aldimine 
linkage); however there is evidence of a low occupancy presence of a PLP-internal 
aldimine with Lys197. In addition to the product, we also observe a weak presence of the 
substrate, L-Ser that superimposes closely with the Gly. The Cα-Cβ bond of L-Ser bound 
as an external aldimine to PLP is nearly orthogonal with the plane of the pyridoxal ring 
(81
0) to make maximum electronic interactions with the π system of PLP. The 
carboxylate group of glycine (and L-Ser) displaces the water molecules seen co-ordinated 
to Arg308 in the native structure and makes hydrogen bond interactions with Arg308 and 
Arg169. The bound L-Ser makes additional interactions through its hydroxyl moiety with 
the side chain of His126 and His83, as well as with a water molecule which mediates the 
interaction with the PLP phosphate.  Unlike the native and the eTA/ Ser5.6 structures, 
His126 of this structure is disordered. The OH of L-Ser is also located between the side-
chains of His83 and His126, but compared to the eTA/ Ser5.6 structure, the interaction 
between the OH of L-Ser and His126 seems to be weaker and His83 stronger  
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Structural details of eTA in complex with L-Threonine at pH 7.5 (eTA/ Thr7.5): 
We have also studied the complex structure between eTA and L-Thr at 
physiological pH of 7.5, to understand the difference in mode of binding and subsequent 
catalysis (if any) of varied substrates by eTA. The eTA/ Thr7.5 complex structure is 
isomorphous to the native structure and crystallized with a dimer in the asymmetric unit 
as well. The rmsd between the two structures is 0.2Å, suggesting similar conformation.  
Shown below in Figure 24 is the active site of eTA/ Thr7.5. Similar to the 
structures described above, eTA/ Thr7.5 shows bound PLP at the active site, recognized 
Figure 23: The active site residue of eTA/ L-Serine complex at pH 7.5. The product 
Gly is seen bound to PLP as an external aldimine. Gly and L-Ser are superimposed 
with each other at the active site and bound as external aldimine to PLP.  
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by residues described for the native eTA structure. As observed in eTA/ Ser7.5 structure, 
PLP forms an external aldimine with the product glycine, with evidence of low 
occupancy of substrate L-Thr bound external aldimine. There is no evidence of internal 
aldimine formation in either of the two subunits in eTA/ Thr7.5 structure. The angle 
between the Cα-Cβ bond of L-Thr and the plane of the pyridoxal ring is 88.50, consistent 
with the Dunathan hypothesis that for optimum reactivity the Cα-Cβ should be nearly 
orthogonal to the plane of the pyridoxal ring of PLP. Again, the carboxylate group of 
glycine (and L-Thr) displaces the water molecules seen co-ordinated to Arg308 in the 
native structure and makes hydrogen bond interactions with Arg308 and Arg169. The 
bound L-Thr makes hydrogen bond interactions with the side chains His83, weak 
hydrogen bond interactions with His126 and a water molecule as described above for the 
L-Ser in eTA/ Ser7.5 structure.  His126 is also disordered in this structure. In comparison 
with the eTA/ Ser5.6 or eTA/ Ser7.5 structures, the hydroxyl group of L-Thr seems to be 
located closest to His83 but furthest from His126.  
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Modeling L-allo-Thr into the active site of eTA/ Thr7.5: 
Although the natural substrates of eTA are L-threonine and L-allo-threonine, the 
enzyme has significant preference for L-allo-threonine. To understand the basis of this 
substrate specificity, and in the absence of a co-crystal structure of L-allo-threonine with 
eTA, we modeled this ligand into the active site of eTA/ Thr7.5 complex based on the 
binding mode of L-Thr (Figure 25). If the two hydroxyl groups are superimposed, the 
methyl group of L-allo-Thr which is disposed in a different direction from that of L-Thr 
is found to sterically clash with the side chain carbon of His83 (Figure 25). Due to the 
freely rotatable bond at Cβ carbon of L-allo-Thr, the methyl group probably moves away 
Figure 24: The active site residue of eTA/ L-Threonine complex at pH 7.5. The 
product Gly and substrate L-Thr bound to PLP as external aldimine.  
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from His83 to relieve the steric clash. A consequence of this action would be the 
hydroxyl group of L-allo-Thr moving closer to His83 but further away from His126 
(Figure 26). Note that the methyl group of L-Thr shows no such steric clash and its 
hydroxyl group is almost equidistant from both His83 and His126 (Figure 25 and Figure 
26). Thus, it seems that the enzyme selects between L-Thr and L-allo-Thr based on the 
methyl group position.  
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Figure 25: Hydroxyl group of L-threonine bound as external aldimine (Pink) is 3Å 
and 3.1Å from His83 and His126, respectively. L-allo-threonine (magenta) has been 
modeled into the density observed for L-threonine. Hydroxyl group is at hydrogen 
bonding distance from His83 but the methyl group makes steric interaction with the 
side chain carbon of His83.  
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2.3.3 Catalytic Mechanism of eTA: 
To draw a clear picture of the catalytic mechanism and substrate specificity of 
eTA, we have determined the crystal structures of native eTA and its complex with 
substrate and/or product at different pH’s for comparative studies. Comparative analysis 
of eTA structures with SHMT as well as with TTA structures also provided important 
information about probable roles of active site residues in the catalytic mechanism of 
eTA.  
Figure 26: Hydroxyl group of L-threonine bound as external aldimine (Pink) and 
3.2Å from His83 and His126, respectively. L-allo-threonine (cyan) has been modeled 
to be at an acceptable distance from the side chain carbon of His83. Hydroxyl group is 
now closer to His83 but further away from His126, while the steric clash between the 
methyl group and the side chain carbon of His83 is relieved  
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Kinetic data of mutants of the active site residues of eTA was also very useful in 
understanding the mechanism of the enzyme in greater details. The mutation studies were 
performed by our collaborators at the University of Rome and their findings (unpublished 
data) is used to make meaningful interpretations of our structures. 
Catalytically Significant Residues:  
The role of the active site residues His83, His126, Phe87 and Glu88 is examined 
in greater details to propose a mechanism for the retro-aldol cleavage of β-hydroxy amino 
acids. An overview for the mechanism of the reaction involves abstraction of the 
hydroxyl proton from the substrate bound external aldimine, followed by formation of 
product glycine bound external aldimine and subsequent regeneration of the internal 
aldimine. The enzyme also selectively catalyzes the retro-aldol cleavage of L-allo-Thr > 
L-Thr > L-Ser. The residues involved in the mechanism of retro-aldol cleavage as well as 
the selection process have been identified here.  
 
His83 as the catalytic base: 
His83 at the active site has been proposed to be the catalytic base which is 
involved in the abstraction of the hydroxyl proton of the β-hydroxy amino acid during the 
retro-aldol cleavage reaction.  
In the crystal structure of eTA/ Ser5.6, the hydroxyl group of L-Serine makes 
very weak interaction with His83, preventing optimal abstraction of the hydroxyl proton, 
and as a result the enzyme does not catalyze L-Ser. In comparison, the crystal structure of 
eTA/ Thr7.5 and eTA/ Ser7.5 have the hydroxyl groups of L-Thr and L-Ser, respectively, 
closer to His83, which resulted in the turnover of these substrates to their corresponding 
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products. The hydroxyl group of L-Thr in eTA/Thr7.5 complex is closer to His83 when 
compared to the hydroxyl group of L-Ser in eTA/ Ser7.5, and this is reflected in higher 
kcat for the L-Thr (Table 12).  The hydroxyl group of the modeled L-allo-Thr is even 
closer to His 83, and expectedly L-allo-Thr has the highest kcat (Table 12).  
Since, His83 is closer to the hydroxyl group of L-allo-Thr , this residue seems to 
influence the affinity of the enzyme for L-allo-Thr significantly. Mutation of His83 to 
Phe loses the hydrogen bonding capability to this ligand resulting in a 30-fold increase in 
the Km of L-allo-Thr. Asn is capable of making weak hydrogen bond interactions with 
the hydroxyl group of L-allo-Thr, hence only an eight fold decrease in affinity is 
observed with the H83N mutant (Table 12).  
With L-Thr catalysis, hydrogen bond interactions with both His83 and His126 
seem to influence the Km values. H83F mutant shows a three-fold decrease in Km values 
when L-Thr is the substrate (Table 12, Figure 27). Although Phe lacks the ability of 
forming hydrogen bond interactions with the hydroxyl group of L-Thr, we speculate that 
the hydroxyl group of L-Thr is pushed closer to His126 in H83F mutants due to steric 
interaction with Phe. This results in a stronger hydrogen bond interaction between the 
hydroxyl group and His126 that increased the affinity of the substrate for the mutant, 
nevertheless the kcat is reduced significantly because of the loss of the catalytic base. In 
the H83N mutants, Asn obviously can still make hydrogen-bond interaction with the 
hydroxyl group of L-Thr but probably weaker compared to the His, resulting in the 
observed two-fold increase in Km.  
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Substrate            WT          H83F        H83N 
 kcat     Km    kcat / Km  kcat     Km     kcat / Km  kcat     Km    kcat / Km  
L-threonine 112     19.4    5.8 1.2      7       0.17 17       38       0.4 
L-allo-threonine 213     0.24    887 3.7      7       0.53  77      1.7       45 
L-Serine  1.9     16       0.11   -        -          -   -        -        - 
Table 12: The table shows the kinetic data of His83 mutants. Also, shown is the kinetic 
data of L-Ser cleavage in wild type enzyme 
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A mechanism has been proposed here based on the structural and mutagenesis 
studies involving His83 as the catalytic base (Figure 28). The external aldimine formed 
between the substrate L-Thr and the aldehyde group of PLP positions the hydroxyl group 
of L-Thr close to His83. The mechanism based on the earlier proposal of His83 to be the 
catalytic base involves abstraction of the L-Thr hydroxyl proton and generation of the 
quinonoid complex (Step I and II). The abstraction of the hydroxyl proton by His83 will 
be enhanced by a residue with an acidic side chain, Glu88 in Step I. The bond angle and 
bond distances between the hydroxyl proton and His83 are optimum for proton 
abstraction. On examination of the L-Thr and Gly bound external aldimines, we observe 
Figure 27: Hydroxyl group of L-threonine (yellow) bound to PLP is close to His83 to 
make hydrogen bond interactions with it. The hydroxyl group of the modeled L-allo-
Threonine (cyan) is closer to His83. This figure also depicts the mutation of His83 to 
Asn (magenta) and Phe (blue) in the structure of eTA/ Thr7.5 complex. 
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a water molecule to occupy the position of hydroxyl group of   L-Thr in Step II. This 
water molecule could be involved in generation of the Gly bound external aldimine. The 
basicity of this water molecule to act as a nucleophile in Step II is enhanced by a water 
mediated interaction with the phosphate group of PLP.   
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The site-directed mutational studies by our collaborators shows some decrease in 
the catalytic function of eTA with L-Thr (L-allo-Thr or L-Ser) when His83 is replaced 
with either Asn or Phe (Table 12). However, this decrease in catalytic function is not 
significant enough to render His83 as the sole base in the catalysis of β-hydroxy amino 
acids. Thus, His83 does not seem to be the active site base but it seems to be in the 
involved in catalysis and may have some different, nevertheless important function. We 
believe that His83 might be involved in substrate position at the active site owing to its 
favorable position in the catalytic apparatus  
 
 
Figure 28: Retro-aldol cleavage mechanism with His83 as the active site base  
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It seems unlikely that His83 could act as the catalytic base in the retro-aldol 
cleavage reaction. Hence, an alternate mechanism with a more plausible basic candidate 
was proposed (Figure 29). The reaction commences as pointed earlier, with the substrate 
(L-Thr) forming an external aldimine with the co-factor PLP. We propose that a spacially 
close water molecule acts as the catalytic base that abstracts the hydroxyl proton from the 
bound L-Thr (Step I). This water molecule, W1 is a good enough nucleophile owing to its 
proximity to the negatively charged phosphate group of PLP. The concomitant release of 
the aldol reaction acceptor aldehyde generates a quinonoid complex (Step II). A second 
water molecule, W2 acts as the acidic group involved in generation of the product glycine 
bound external aldimine from the quinonoid complex (Step II and IV). The acidity of W2 
is enhanced by His83 which is at a distance of around 2.9Å. The possibility of a single 
water molecule, W1 that interposes between phosphate group of PLP and the Cα of the 
quinonoid complex performing simultaneously the functions of the catalytic base cannot 
be ruled out. However, W1 has to move closer to the Cα of the quinonoid complex to also 
perform the function of W2. Our proposed mechanism involving two water molecules 
instead of one or His83 is more reasonable and probable. Additional kinetic experiments 
need to be performed to substantiate this mechanism.  
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Figure 29: Alternate mechanism proposed for the retro-aldol cleavage reaction with 
water molecule acting as the active site base  
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His126 as Substrate Specificity Determinant: 
Like His83, His126 has also been proposed to be the catalytic base. The mutational 
studies clearly suggest otherwise since mutating the residue results in increase in kcat 
(Table 13).  Rather we propose that His126 may be acting as the substrate specificity 
determinant. Comparative analysis of native eTA structure with eTA/ Thr7.5, eTA/ 
Ser7.5 and eTA/ Ser5.6 (Figure 30) suggest that His126 may be acting as a ‘gating 
residue’, affecting substrate entry and catalysis at the active site.   
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Our hypothesis is that the hydrogen bond interactions between the substrate and 
His126 dictate the entry of substrates into the active site, as well as optimal positioning of 
the substrate for catalysis. Consistently, in the eTA/ Ser5.6 structure where the hydroxyl 
group of L-Ser makes closer interaction with His126 the substrate is further removed 
from the proposed base, His83 and shows almost no catalytic activity with the substrate 
Figure 30: eTA native (yellow) structure at pH7.5 superimposed on eTA/ L-Serine 
complex at pH 5.6 (magenta), eTA/ L-threonine complex at pH 7.5 (blue) and eTA/ 
L-serine complex at pH 7.5 (cyan) 
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being trapped at the active site. eTA/ Ser7.5 structure shows the hydroxyl group of L-Ser 
to be making weaker hydrogen bond interactions to His126 and in eTA/ Thr7.5 structure 
interaction of the hydroxyl group of L-Thr with His126 is even weaker, and consistently 
the catalysis of  L-Ser is slower than L-Thr at pH 7.5. When L-allo-Thr is modeled at the 
active site, there is negligible interaction of the hydroxyl group of L-allo-Thr with His126 
consistent with the maximum catalytic turnover of this substrate. Thus, the strength of the 
interaction between the hydroxyl group of the substrates and the side chain of His126 
decreases from L-Ser at pH 5.6 > L-Ser at pH 7.5 > L-Thr at Ph 7.5. This trend is 
reversed with respect to interaction with His83 as described above and concomitantly 
with kcat.  
The theory of His126 being a substrate specificity determinant, is substantiated by 
the mutation study since mutation of His126 results in decrease in substrate specificity 
from 150 [(kcat / Km)L-allo-Thr to (kcat / Km)L-Thr] to 13 and 120 for H126F and H126N 
mutants respectively (Table 13).  
As expected, the kcat for L-allo-Thr and L-Thr increase with the H126F mutant 
which abrogates hydrogen bond interaction if any with residue at position 126. 
Replacement with Asn126 also leads to increase in kcat but expectedly smaller than 
observed with the Phe mutant as Asn126 can still make weak attraction to the substrate 
(Table 13.).  
We observe no significant change or slight increase in the Km of L-allo-Thr in the 
H126Fand His126N mutants.  This is also expected since in case of L-allo-Thr, 
interaction with His126 is very weak and therefore any change at this position should not 
significantly affect the affinity of L-allo-Thr. Nevertheless, with L-Thr we observe a 
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decrease in Km for the H126F mutant but an increase in the Km in the H126N mutant. 
Phe seems to sterically push the hydroxyl group to His83 which may explain the decrease 
in Km. Asn, on the other hand still make interaction with the hydroxyl group but weaker, 
explaining the increase in Km.     
  
 
 
 
 
 
 
 
 
 
 
 
 
Substrate           WT        H126F       H126N 
 kcat      Km    kcat /Km   kcat     Km    kcat /Km   kcat      Km   kcat /Km   
L-threonine 112     19.4    5.8 360    1.7       212 262     61          4 
L-allo-threonine 213     0.24    887 541     0.2     2705  469    0.96       488 
L-Serine  1.9     16       0.11   -        -          -   -        -        - 
Table 13: The table shows the kinetic data of His126 mutants. Also, shown is the kinetic 
data of L-Ser cleavage in wild type enzyme  
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Thus, to summarize, there is an interplay between the role of His83 and His126 to 
influence the affinity of the enzyme for L-Thr and its subsequent catalysis (Figure 31). In 
the case of L-allo-Thr, His83 seems to be the determinant for both affinity of eTA for the 
substrate and rate of catalysis since the hydroxyl group of  L-allo-Thr is closer to His83 
(Figure 32).   
 
Figure 31: Hydroxyl group of L-threonine (yellow) bound to PLP is close to His126 to 
make hydrogen bond interactions. The hydroxyl group of the modeled L-allo-
Threonine (cyan) is closer to His83. This figure also depicts, His126 mutated to Phe 
(purple) and Asn (magenta).  
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Other residues at the active site:  
Another important residue at the active site that indirectly influences the catalysis 
is Glu88. Glu88 (Figure 33) makes close hydrogen bond interactions (between 2.6-2.8 Å) 
with the side chain of His83. This acidic residue seems to be involved in increasing the 
basicity of His83 and enhance its ability to abstract protons. Mutation of Glu88 with Gln 
(Table 14) results in reduced rate of catalysis with both, L-Thr and L-allo-Thr. This is 
most likely due to the fact that the neutral Gln is not as capable in enhancing the basicity 
of His83 compared to Glu. The associated increase in Km with L-Thr in E88Q mutants is 
not explained by our structural findings. 
Figure 32: L-allo-threonine (magenta) is closer to His83 while L-Threonine 
(yellow) is equidistant from His83 and His126. 
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Phe87 (Figure 33) is another residue present at the active site that seems to be 
important in catalysis. Mutation of this residue has deleterious effect on the rate of 
catalysis of either of L-Thr and L-allo-Thr (Table 14). Interestingly, Phe87 is too far 
away from the active site (more than 5 Å away) from the bound ligands to make any 
direct and meaningful interactions with the substrate. Nevertheless, its close association 
with other hydrophobic residues adjacent to the active site highly suggests this residue to 
be important in maintaining the structural integrity of the active site. Most likely, 
mutation of this residue results in significant change in the active site structure with a 
concomitant effect on the catalysis.  
 
 
 
 
 
 
 
 
 
 
Substrate          WT        F87A         E88Q 
 kcat      Km    kcat /Km      kcat      Km    kcat /Km    kcat      Km    kcat /Km    
L-threonine 112     19.4    5.8  43       8.7      4.9 6.4     49      0.13 
L-allo-threonine 213     0.24    887 160     0.31     516 67.2   0.21   319 
Table 14: The table shows the kinetic data of Phe87 and Glu88 mutants.  
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During external aldimine formation with PLP, Arg308 (Figure 33) forms salt 
bridges with the carboxylate group of the substrates and positions the hydroxyl group for 
ready abstraction of the proton by the base for the retro-aldol reaction, His83. Although, 
mutation studies to substantiate this observation is lacking, the residue is conserved in 
SHMT structures and has the same role as indicated here.  
We have also observed, Cys194 (not shown in Figure 31) that seems to hydrogen 
bond (3.17Å) to the free Lys197 (when PLP is in the external aldimine form). We think 
that Cys194 positions Lys197 into the active site for regeneration of internal aldimine. 
Cys194 makes close hydrogen bond interactions with the residue Ser205 in the native 
structure while in case of an eTA/ substrate complex (E.g.: eTA/ Thr7.5) it makes 
hydrogen bond interactions with the free Lys197 as well as Ser205.  
 
Figure 33: Active site residues depicted in eTA/ L-threonine complex. Other active 
site residues of eTA are depicted here, namely Glu88 and Phe87.  
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Structural comparison between eSHMT and eTA:  
eSHMT structure has been studied in great details and several residues have been 
implicated to have varied functions with an ultimate result of achieving substrate and 
reaction specificity. eTA active site is more open as compared to the active site of 
eSHMT. In eSHMT structure, the initial amino acids at amino terminus extend away 
from their respective monomer and wrap around the other monomer to form a tight 
catalytic dimer. This is not seen with eTA where the amino terminus is held within the 
monomer (Figure 34). This is probably the reason that the active site of eSHMT is 
extensively made up of residues from both the sub-units of the catalytic dimer while in 
eTA, only a His126 from the other sub-unit is accessible to the active site. 
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The rmsd between the monomers of eSHMT and native/ eTA is 1.2 Å. The 
catalytic dimers are also very different with an rmsd of 4.3 Å. Even with large structural 
differences the two enzymes belong to the same fold, Fold Type I of PLP-dependent 
enzymes  and  can catalyze retro-aldol cleavage of several β-hydroxy amino acids and 
also racemization and transamination reactions. Consistent with the difference in 
substrate specificity of the two enzymes, their active sites are designed to accept the 
respective physiological substrate.  
Comparative analysis of the two structures has revealed that some of the residues 
at the active site of eSHMT are conserved while a few are seem to be unique to eSHMT. 
A conserved Lys229 (Lys197 in eTA) forms an internal aldimine with PLP. His126 of 
eSHMT (different from His126 in eTA but corresponding to His83 in eTA) forms π-
Figure 34: Monomer of native eTA (cyan) superimposed on monomer of 
eSHMT (magenta) showing an extra loop from the amino terminal of eSHMT 
that wraps around the other monomer to form the tight dimer. 
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stacking interactions with the pyridoxal ring of PLP from the re face and Ala202 (Ala 
168 in eTA) interacts with PLP from the si face. A threonine residue (Thr128) is in close 
proximity to His126 in eSHMT while in eTA a glutamate residue (Glu88) is close to the 
conserved His83. Glu88 of eTA seems to enhance the proton abstraction by His83 of 
eTA and thus, His83 has been proposed to be the base in the retro-aldol cleavage 
reaction. His126 has not been implicated as a base in eSHMT catalysis probably because 
a threonine residue (Thr128 in close proximity to His126) lacks the ability to increase the 
proton abstraction capability of the basic residue, His126 as compared to Glutamine 
residue in eTA. Other residues like Asp200 (Asp166 in eTA) and Ser175 (Arg169 in 
eTA) that interacts with the PLP are also conserved. 
Tyr65’ in eSHMT interposes between L-Ser (substrate for SHMT) and THF 
(another co-factor required for SHMT) and this interposition is associated with a 
conformational change in the catalytic dimer of eSHMT leading to the conversion of the 
enzyme from an ‘open’ to a ‘closed’ structure to ensure reaction specificity61. A residue 
that corresponds to Ty65’ of eSHMT has not been identified for eTA and the occurrence 
of an open and a closed structure in eTA has not been ascertained (although His126 has 
been identified as a substrate specificity determinant). But some degree of displacement 
of the small domains of the monomers of native and the substrate bound structures of 
eTA is evident during comparative analysis of the structures and may be indicative of 
conformational changes associated with achieving reaction specificity in eTA as well. 
The most significant difference between the two enzymes is the conspicuous 
absence of the binding site for the co-factor, THF in eTA (Figure 33). eTA can catalyze 
the retro-aldol of L-Ser and does not require this second co-factor.  eSHMT catalyzes the 
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retro-aldol cleavage of L-Serine in the presence of THF. In the absence of this co-factor, 
eSHMT (and all other SHMTs) catalyzes the retro-aldol cleavage of other β-hydroxy 
amino acids at increasingly high rates. It may be inferred that THF is involved in the 
substrate selectivity. His126 of eTA occupies the spacial position of THF found bound to 
eSHMT (Figure 35). This above observation substantiates the hypothesis from our 
current structural studies that His126 is a substrate specificity determinant.  
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Figure 35: THF (orange) of eSHMT (magenta) is an important co-factor in the retro-aldol 
cleavage of L-serine. Important active site residues of native eTA (cyan) are also shown in 
the figure.  
 
  
90 
 
Structural comparison of Thermatoga maritima L-TA (TTA) with eTA: 
Comparative studies were also done between TTA and eTA to understand the 
mechanism and the function of the active site residues in greater details. The monomers 
of TTA and eTA are similar with an rmsd of 0.9 Å but the catalytic dimers of the two 
enzymes are quite different with an rmsd of 1.1 Å.  
The residues of the active site are also conserved between the two enzymes 
(Figure 36). PLP forms a Schiff base with Lys199 (Lys197 of eTA) of each monomer. 
PLP is recognized by Asp168 and Arg171 (Asp166 and Arg169 in eTA). The Cα-Cβ 
bond is almost orthogonal (100
0
) to the pyridoxal ring of PLP which compares to 88.5
0
 in 
eTA/ Thr7.5 structure.  
As seen in Figure 36, His125 in TTA is localized into the active site from the 
other monomer (His126 in eTA). This residue has not been implicated to be of 
significance in substrate selection in TTA as we propose here for eTA.  
Tyr 87 (Phe87 in eTA) as shown in Figure 36 has been implicated in as the 
substrate selectivity determinant in TTA, although it is about 5Å away from the substrate. 
Phe87 of eTA is also more than 5Å away from the active site for it to make any 
meaningful interactions with either the substrate or with any residue directly important 
for catalysis. As discussed, it may be that Phe87 maintains the structure of the active site 
which indirectly effects substrate catalysis but its possible proximity to the substrate 
during inter-domain movement cannot be ruled out. His83 in TTA (His83 in eTA) 
structure stacks on top of pyridoxal ring of PLP and has been implicated as a base of the 
retro-aldol cleavage reaction. His83 in eTA has also been suggested to be the base for the 
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retro-aldol cleavage reaction in our structural studies and this hypothesis is supported by 
the results of mutation studies performed by our collaborators.    
In the native TTA structure, five water molecules are seen at the active site. Two 
of the water molecules form hydrogen bond interactions with Arg316. These waters are 
also seen in the eTA structure co-ordinated to Arg 308. Another water molecule makes 
close hydrogen bond interactions with the phosphate group of PLP and slightly weaker 
hydrogen bond interactions with His125 in TTA. This water molecule is also conserved 
in eTA structures and has been implicated to be important in the catalysis in the current 
study (See Alternate Mechanism, Figure 29).  
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Figure 36: Active site of native eTA (blue) structure is superimposed on active site of 
native TTA (green) structure (eTA residues have been named in this figure). 
Corresponding TTA residues are mentioned in the text above. The conserved water 
molecule is shown in yellow.  
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2.4 Conclusion: 
Crystal structures of eTA were solved in the presence and in the absence of ligands 
(β-hydroxy amino acids) at pH 7.5 as well as pH 5.6. Pyridoxal ring PLP seems to 
undergo some degree of rotation between its position in the native and substrate bound 
structures. eTA/ Ser7.5 and eTA/ Thr7.5 show the presence of low occupancy presence of 
substrate and product bound external aldimine at the active site. eTA/ Ser7.5 structure 
shows the presence of very low percentage of internal aldimine with PLP as well. Crystal 
structure of eTA/ Ser5.6 showed the presence of an abortive complex of L-Serine with 
eTA at the active site.   
Orientation of His126 seems to be altered between native and substrate bound 
structures and His126 is proposed to be the substrate specificity determinant in the retro-
aldol cleavage of β-hydroxyl amino acids. His83 stacks on top of the pyridoxal ring of 
PLP and is deduced to be the base that abstracts the proton from the hydroxyl group of β-
hydroxyl amino acids. Glu88 is positioned to make favorable interactions with His83 and 
seems to enhance proton abstraction by His83. Phe87 seems to provide structural 
integrity to the active site. Salt bridges between Arg308 and the carboxylate groups of the 
substrates are observed in substrate bound structures and may be involved in positioning 
the substrate at the active site. The proposed roles of the residues are substantiated by the 
wealth of information provided by mutagenesis studies performed by our collaborators at 
the University of Rome.  
An appreciable degree of movement in evident in the small domains of individual 
monomers of native eTA and eTA/ substrate complexes but the rmsd between the 
structures is very low to make conclusions about the occurrence of open and closed 
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structures in eTA. But based on the movements seen in the small domains it may be 
inferred that the enzyme achieves reaction specificity by maintaining a closed 
conformation of the active site as was seen in eSHMT.  
eSHMT structure served as a very good model to draw comparison between eTA 
and other PLP-dependent enzymes. eSHMT catalyzes retro-aldol cleavage of L-Serine in 
the presence of THF. eTA catalyzes the same reaction in the absence of THF. Through 
our current study and future work we are trying to understand the evolution of THF 
binding site in eSHMT.  
A mechanism for retro-aldol cleavage reaction of β-hydroxy amino acids inspired 
by the mechanism of L-Serine cleavage by SHMT is proposed in our current study. His83 
is suggested as the base that abstracts a proton from the hydroxyl group of the substrate 
bound to PLP as an external aldimine. This is followed by the generation of a quinonoid 
intermediate which is converted to product bound external aldimine. An acidic moiety is 
involved in this conversion. A water molecule adjacent to the phosphate group of PLP, 
redundant in the native/ eTA and eTA/ substrate bound structures is suggested to be the 
candidate that performs this function.  
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2.5 Future Directions:  
1.  Molecular dynamics studies may be performed to confirm our hypothesis of 
hydrogen bonding of the substrates to His126 during their entry into the active 
site for their subsequent selection for catalysis as well as the occurrence of a 
closed conformation for the retro-aldol cleavage reaction to ensure reaction 
specificity.  
2.  Since eTA is a PLP accepting enzyme and future work may be directed towards 
understanding the mechanism of PLP transfer from PLP-donor enzymes, the 
pyridoxal kinases to eTA. 
3.  The origin of THF binding site may be studied to draw correlation between PLP-
dependent enzymes.  
4.  Engineering of eTA to serve as a better biocatalyst is also a significant future 
work.  
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